Evidence map›Paper›PMID 27439461›Full record

ArticleBMC medical genetics2016

Novel mutation in the CHST6 gene causes macular corneal dystrophy in a black South African family.

Nadia Carstens, Susan Williams, Saadiah Goolam, Trevor Carmichael, Ming Sin Cheung, Stine Büchmann-Møller, Marc Sultan, Frank Staedtler, Chao Zou, Peter Swart and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Novel compound heterozygous mutations in theAnnals of translational medicine · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Nadia CarstensSydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, 2050, Johannesburg, Gauteng, South Africa.
Susan WilliamsDivision of Ophthalmology, Department of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa.
Saadiah GoolamDivision of Ophthalmology, Department of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa.
Trevor CarmichaelDivision of Ophthalmology, Department of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa.
Ming Sin CheungBiomarker Development, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Stine Büchmann-MøllerBiomarker Development, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Marc SultanBiomarker Development, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Frank StaedtlerBiomarker Development, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Chao ZouCenter for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Peter SwartDivision of Anatomical Pathology, National Health Laboratory Services and University of the Witwatersrand, Johannesburg, South Africa.
Dennis S RiceNovartis Institutes for Biomedical Research, Cambridge, USA.
Arnaud LacosteNovartis Institutes for Biomedical Research, Cambridge, USA.
Kim PaesNovartis Institutes for Biomedical Research, Cambridge, USA.
Michèle RamsaySydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, 2050, Johannesburg, Gauteng, South Africa. michele.ramsay@wits.ac.za.
University of the Witwatersrand · ZANovartis Institutes for BioMedical ResearchNovartis (United States) · USNovartis (Switzerland) · CH

Funding

Wits Non-communicable Disease Research Leadership ProgramD43TW008330 · FIC · WITS HEALTH CONSORTIUM (PTY), LTD · PI CROWTHER, NIGEL JOHN, KLIPSTEIN-GROBUSCH, KERSTIN · 2010 to 2014
$985k
FIC NIH HHS D43 TW008330
6 · The paper itself

Abstract

backgroundMacular corneal dystrophy (MCD) is a rare autosomal recessive disorder that is characterized by progressive corneal opacity that starts in early childhood and ultimately progresses to blindness in early adulthood. The aim of this study was to identify the cause of MCD in a black South African family with two affected sisters.

methodsA multigenerational South African Sotho-speaking family with type I MCD was studied using whole exome sequencing. Variant filtering to identify the MCD-causal mutation included the disease inheritance pattern, variant minor allele frequency and potential functional impact.

resultsOphthalmologic evaluation of the cases revealed a typical MCD phenotype and none of the other family members were affected. An average of 127 713 variants per individual was identified following exome sequencing and approximately 1.2 % were not present in any of the investigated public databases. Variant filtering identified a homozygous E71Q mutation in CHST6, a known MCD-causing gene encoding corneal N-acetyl glucosamine-6-O-sulfotransferase. This E71Q mutation results in a non-conservative amino acid change in a highly conserved functional domain of the human CHST6 that is essential for enzyme activity.

conclusionWe identified a novel E71Q mutation in CHST6 as the MCD-causal mutation in a black South African family with type I MCD. This is the first description of MCD in a black Sub-Saharan African family and therefore contributes valuable insights into the genetic aetiology of this disease, while improving genetic counselling for this and potentially other MCD families.

Indexed as

MutationAdultCarbohydrate SulfotransferasesCorneaCorneal Dystrophies, HereditaryFemaleHigh-Throughput Nucleotide SequencingHomozygoteHumansMalePedigreePhenotypePolymorphism, Single NucleotideSouth AfricaSulfotransferasesCarbohydrate SulfotransferasesSulfotransferasesAfricanCHST6Macular corneal dystrophyWhole exome sequencing

Identifiers

PMID27439461
PMCPMC4955246
OpenAlexW2493303099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.